| Treatment of patients with chronic granulomatous disease with recombinant human interferon-gamma does not improve neutrophil oxidative metabolism, cytochrome b558 content or levels of four anti-microbial proteins. | |
| | |
MedLine Citation:
|
PMID: 1572085 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Recombinant interferon-gamma (rIFN-gamma) has been described to enhance phagocyte functions in vitro and in vivo in several patients with chronic granulomatous disease (CGD). To demonstrate the clinical usefulness of this treatment, 128 patients were treated in a randomized, double-blind multi-centre study with a placebo preparation or with rIFN-gamma. We analysed parameters of neutrophil oxidative and non-oxidative metabolism in 16 patients enrolled in this study. No enhanced superoxide-release was observed in patients treated with rIFN-gamma compared to placebo-treated patients. Phagocyte cytochrome b558 content also remained unchanged. Levels of four non-oxidative antimicrobial proteins (cathepsin G, azurocidine, p29b, lactoferrin) rose, fell, or remained unchanged, irrespective of treatment with rIFN-gamma or placebo. |
| | |
Authors:
|
T J Mühlebach; J Gabay; C F Nathan; C Erny; G Dopfer; H Schroten; V Wahn; R A Seger |
Related Documents
:
|
23515605 - Late-onset systemic lupus erythematosus: clinical features, course, and prognosis. 23176375 - Acupuncture for cerebral vasospasm after subarachnoid hemorrhage: a retrospective case-... 22993465 - Varied aetiology of acute acquired comitant esotropia: a case series. 23612675 - Endothelial dysfunction in graves' disease. 6152785 - Zinc deficiency in mild hypertensive patients treated with diuretics. 15655095 - Factors influencing medical treatment of heart failure patients in spanish internal med... |
Publication Detail:
|
Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Clinical and experimental immunology Volume: 88 ISSN: 0009-9104 ISO Abbreviation: Clin. Exp. Immunol. Publication Date: 1992 May |
Date Detail:
|
Created Date: 1992-06-02 Completed Date: 1992-06-02 Revised Date: 2009-11-18 |
Medline Journal Info:
|
Nlm Unique ID: 0057202 Medline TA: Clin Exp Immunol Country: ENGLAND |
Other Details:
|
Languages: eng Pagination: 203-6 Citation Subset: IM |
Affiliation:
|
Division of Immunology-Haematology, University Children's Hospital, Zürich, Switzerland. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Blood Proteins
/
drug effects,
immunology Cytochrome b Group / deficiency, drug effects Female Granulomatous Disease, Chronic / drug therapy*, immunology Humans Immunoglobulin G / drug effects Interferon-gamma, Recombinant / therapeutic use* Male NADH, NADPH Oxidoreductases / drug effects NADPH Oxidase Neutrophils / drug effects |
| Chemical | |
Reg. No./Substance:
|
0/Blood Proteins; 0/Cytochrome b Group; 0/Immunoglobulin G; 0/Interferon-gamma, Recombinant; 9064-78-2/cytochrome b558; EC 1.6.-/NADH, NADPH Oxidoreductases; EC 1.6.3.1/NADPH Oxidase |
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: B cell responses to HIV and the development of human monoclonal antibodies.
Next Document: Acute rejection in heart transplant patients is associated with the presence of committed donor-spec...